A new report from Telligen has found that pharmacists are well-positioned to prevent anticoagulant-related adverse drug events (ADEs) and improve care coordination for patients utilizing their service.
The study used electronic medical record (EMR) extrapolation and manually reported intervention data, and found that in nine months, the pharmacist prevented over 370 anticoagulant-related ADEs and saved over $750,000. Nearly 40 percent of patients received a pharmacist intervention.
Additional benefits included improved care coordination between the hospital and anticoagulation clinic and more time post-discharge anticoagulation management for patients.
